Answers are grounded in this paper and cite their sources.
BACKGROUND: Transgender and gender-diverse (TGD) people face disproportionately high rates of discrimination, violence, and social rejection. TGD people in the United States also exhibit increased rates of substance use. There is, however, little empirical evidence describing the association between substance use and minority stress among TGD people in the United States. METHODS: Between August and December 2023, TGD individuals receiving gender-affirming care in San Francisco (N = 103) were recruited to complete an anonymous survey. Participants completed the Gender Minority Stress and Resilience Measure (GMSR), described past/present substance use, and provided demographic information. RESULTS: 53.4% (n = 55) of participants reported using one or more illicit substances in their lifetime. Mean scores of lifetime substance users were significantly higher than nonusers in two distal stressor GMSR subscales: gender-related discrimination (p < .05) and gender-related rejection (p < .05). Lifetime substance users scored significantly higher in two proximal stressor subscales: internalized transphobia (p < .05) and negative expectations (p < .05). Resilience factors had no association with lifetime substance use. CONCLUSIONS: Internalized transphobia, negative anticipations, and experiences of discrimination and rejection are strongly associated with lifetime substance use. These results emphasize the significance of both internal and interpersonal aspects of minority stress and point to potential intervention targets to help reduce substance use disparities among gender minority individuals.
No takes yet. Share an insight, caveat, or question.
Tomlinson et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: